POINT

www.pointbiopharma.com
22 St. Clair Ave. E, Suite 201
Toronto, ON M4T 2S3

Company Info

Phone
(647) 812-2417

Year Established
2020

Ticker
LLY

Exchange
NYSE

Contacts

Joe McCann, Ph.D.
CEO

Bill Demers, FCPA, BBA Bill Demers, FCPA, BBA
CFO

Neil Fleshner, M.D.
CMO

Justyna Kelly, M.Sc.
COO

Matthew Vincent, Ph.D.
Senior VP, Business Deelopment

Company Description

POINT Biopharma, an Eli Lilly company, is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer.